+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 60 Pages
  • December 2022
  • GlobalData
  • ID: 4278898
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


NovoCure Ltd (NovoCure) is focused on the development and commercialization of novel delivery systems for the treatment of cancers of brain, thoracic and abdomen. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division of solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of malignant pleural mesothelioma; and Optune for the treatment of glioblastoma. Both products are indicated in combination with standard chemotherapies. Its product development and clinical programs strive to improve the survival of patients suffering from pancreatic cancer, brain metastases, ovarian cancer, liver cancer, gastric cancer, and non-small cell lung cancer, among others. It has subsidiaries in Europe, the Middle East, Asia, and North America. NovoCure is headquartered in Saint Helier, Jersey, the UK.

NovoCure Ltd Key Recent Developments

Nov 17, 2022: Novocure announces 25 abstracts on tumor treating fields therapy at Society for Neuro-Oncology 2022 Annual Meeting
Nov 15, 2022: Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Sep 21, 2022: Novocure announces Creation of U.S. CNS cancers franchise intended to renew focus on growth in glioblastoma business
Jul 28, 2022: Novocure Reports Second Quarter 2022 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • NovoCure Ltd - Key Facts
  • NovoCure Ltd - Key Employees
  • NovoCure Ltd - Key Employee Biographies
  • NovoCure Ltd - Major Products and Services
  • NovoCure Ltd - History
  • NovoCure Ltd - Company Statement
  • NovoCure Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • NovoCure Ltd - Business Description
  • Geographical Segment: EMEA
  • Performance
  • Geographical Segment: Greater China
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • NovoCure Ltd - Corporate Strategy
  • NovoCure Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • NovoCure Ltd - Strengths
  • NovoCure Ltd - Weaknesses
  • NovoCure Ltd - Opportunities
  • NovoCure Ltd - Threats
  • NovoCure Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • NovoCure Ltd, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • NovoCure Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 28, 2022: Novocure Reports Second Quarter 2022 Financial Results
  • Jul 27, 2022: Novocure announces recipients of 4th Annual AACR-Novocure grants for tumor treating fields research program
  • Apr 28, 2022: Novocure reports first quarter 2022 financial results
  • Apr 08, 2022: Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields
  • Feb 24, 2022: Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
  • Feb 24, 2022: New data finds tumor treating fields initiates downstream anti-tumor response
  • Jan 10, 2022: Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
  • Dec 06, 2021: Novocure announces 4th Annual AACR-Novocure grants for tumor treating fields research program
  • Nov 15, 2021: Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting
  • Nov 15, 2021: 2-THE-TOP Phase 2 Trial reports positive top-line results in newly diagnosed glioblastoma
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • NovoCure Ltd, Key Facts
  • NovoCure Ltd, Key Employees
  • NovoCure Ltd, Key Employee Biographies
  • NovoCure Ltd, Major Products and Services
  • NovoCure Ltd, History
  • NovoCure Ltd, Subsidiaries
  • NovoCure Ltd, Key Competitors
  • NovoCure Ltd, Ratios based on current share price
  • NovoCure Ltd, Annual Ratios
  • NovoCure Ltd, Interim Ratios
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • NovoCure Ltd, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • NovoCure Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • NovoCure Ltd, Performance Chart (2017 - 2021)
  • NovoCure Ltd, Ratio Charts
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • NovoCure Ltd, Medical Equipment, Deals by Type, 2016 to YTD 2022



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Advanz Pharma Corp Ltd
  • Flowonix Medical Inc
  • Monteris Medical Inc
  • MagForce AG
  • SonALASense Inc
  • Hologic Inc
  • MDxHealth SA